cas 1492748-82-9|| where to buy 3-CYCLOBUTYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE

Nombre del producto:3-CYCLOBUTYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE

IUPAC Name:3-cyclobutyl-1,2,4-oxadiazole-5-carbaldehyde

Unidad de embalaje	Stock disponible	Precio($)
CM459226-250mg	3-4 Weeks	ȋƅƩ
CM459226-500mg	4-5 Weeks	Ǡşǆ
CM459226-1g	4-5 Weeks	ȤƩƩ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1492748-82-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1492748-82-9; Fórmula molecular:C7H8N2O2; Punto de fusión:-; Código de sonrisas:O=CC1=NC(=NO1)C1CCC1; Densidad:

: Número de catálogo:CM459226; Peso molecular:152.15; Punto de ebullición:; Nº Mdl:MFCD21117986; Almacenamiento:

: Oxadiazoles; Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.